Camber Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50,000
| Closed | -$2.76M | – | 38 |
|
|
2020
Q3 | $2.76M | Buy |
+50,000
| New | +$2.76M | 0.15% | 33 |
|
|
2020
Q1 | – | Sell |
-730,000
| Closed | -$58M | – | 34 |
|
|
2019
Q4 | $58M | Buy |
+730,000
| New | +$58M | 2.95% | 18 |
|
|
2019
Q2 | – | Sell |
-1,800,000
| Closed | -$95.3M | – | 34 |
|
|
2019
Q1 | $95.3M | Sell |
1,800,000
-450,000
| -20% | -$23.8M | 4.75% | 4 |
|
|
2018
Q4 | $92.4M | Buy |
2,250,000
+175,000
| +8% | +$7.18M | 4.38% | 7 |
|
|
2018
Q3 | $78.9M | Sell |
2,075,000
-125,000
| -6% | -$4.75M | 3.37% | 9 |
|
|
2018
Q2 | $99.4M | Buy |
2,200,000
+1,000,000
| +83% | +$45.2M | 3.83% | 8 |
|
|
2018
Q1 | $58M | Buy |
1,200,000
+400,000
| +50% | +$19.3M | 2.85% | 16 |
|
|
2017
Q4 | $31.5M | Buy |
+800,000
| New | +$31.5M | 1.54% | 19 |
|